We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Sartorius and Bosch Announce Global Collaboration for Aseptic Filling Equipment for Drug Products

By LabMedica International staff writers
Posted on 02 Jul 2012
Print article
Image: The PreVAS aseptic filling system (Photo courtesy of Bosch / Sartorius Stedim Biotech).
Image: The PreVAS aseptic filling system (Photo courtesy of Bosch / Sartorius Stedim Biotech).
Sartorius Stedim Biotech (SSB; Aubagne, France), an international pharma and biotech supplier, and Bosch Packaging Technology (Waiblingen, Germany), one of the leading providers of process technology and packaging solutions for the pharmaceutical industry, announced a long-term global partnership agreement. The agreement covers the mutual design and development of single-use filling solutions to be used on Bosch’s aseptic filling equipment for final fill-and-finish operations of drug products.

SSB will provide Bosch with preconfigured single-use filling transfer sets, consisting of bags, filters, tubing, and connectors. Bosch will combine them with its aseptic filling and barrier isolation technology into new, novel systems for aseptic filling, and exclusively market, distribute, and service these new filling systems under its own brand name.

With the new product line PreVAS (prevalidated, preassembled, presterilized), Bosch will supply its customers with highly cost effective, plug and play tools for aseptic filling operations that provide additional flexibility and come along with comprehensive validation packages. PreVAS will be launched at Achema 2012, held in June 2012 in Frankfurt (Germany).

Joachim Brenner, responsible for Bosch’s pharma liquid product range worldwide and site manager of the plant Crailsheim, stated, “By integrating SSB’s single-use technologies into our aseptic filling systems, we are expanding our product and service portfolio in the area of fill-and-finish unit operations by an important component. With our joint expertise, we intend to develop configurable and customized single-use filling solutions and to provide strong validation and technical support.”

Jean-Marc Cappia, vice president of marketing, fluid management technologies, at SSB, stated, “The partnership with Bosch promotes the implementation of single-use technologies into critical applications such as final filling operations and strengthens the confidence into single-use technology. Our customers from the pharmaceutical and biopharmaceutical industry are facing mounting cost pressure and time constraints. By integrating single-use technology into fill-and-finish unit operations, they can handle smaller batches and product change overs in a safe, economic and flexible way.”

Sartorius Stedim Biotech is a provider of equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, cell cultivation, filtration, purification, fluid management, and lab technologies are supporting the biopharmaceutical industry worldwide to develop drugs safely and cost-effectively.

Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. The company’s manufacturing and R&D sites are in Europe, North America, and Asia, with a global network of sales companies. Its key manufacturing and R&D site is in Germany.

The Bosch division of Packaging Technology is a leading supplier in the field of processing and packaging technology. The company develops and produces solutions for the pharmaceutical, food, and confectionery industries.

Bosch Packaging Technology--Pharma is one of the leading providers of process technology and packaging solutions for the pharmaceutical industry. The portfolio includes single units, systems, and complete solutions for process technology of sterile liquids and powder processing. It also comprises primary packaging for sterile fill and finish and solid dosage forms, secondary packaging as well as inspection technology, qualification, validation services.

Related Links:

Sartorius Stedim Biotech
Bosch Packaging Technology


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.